Awards overview According to the official website of the institute in March 2016, in the 80 years since its establishment, the Institute of Materia Medica has won more than 170 scientific research achievement awards of various types, including 20 national top three awards and the National Science Conference Award. There are 21 awards and 90 provincial and ministerial awards. Some national-level awards Time Name Award Category April 1982 National Technical Invention Award for Muscle Relaxant Levocurare Third Prize July 1982 National Natural Science Award Second Prize for Research on the Site of Analgesic Action and Analgesic Mechanism of Morphine 1982 Research on the active ingredients of Chinese herbal medicine in July 2019 - the discovery of twelve new effective ingredients, the second prize of the National Natural Science Award, June 1985, the third prize of the National Technology Invention Award for the analgesic and anti-inflammatory drug 3-acetylaconitine, June 1985 Animal Experimental Study on the Carcinogenicity of Rubber Anti-aging Agent D, Third Prize of the National Science and Technology Progress Award, December 1987, New True Cholinesterase Inhibitor Drug—Huperzine A (Fuding Base), Second Prize of the National Technology Invention Award, 1988 December 1990/08/11 The fourth prize of the National Technology Invention Award for the antimalarial drug pyrolidine phosphate. The third prize of the National Natural Science Award for the total synthesis research of the plant anti-cancer ingredient maytansine. November 1991 The National Science and Technology Award for dimercaptosuccinic acid. Second Prize of the Progress Award, December 1991, Oxymethylfentanyl - a new highly selective mu-opioid receptor agonist, Second Prize of the National Natural Science Award, December 1991, The relationship between the dopamine nervous system and tetrahydrogen in the brain. The relationship between the pharmacological effects of berberine congeners and the third prize of the National Natural Science Award. Source: Note: For detailed information about the award, see: Paper publication. According to the official website of the institute in March 2016, since 1998, the institute has published more than 3,500 papers. , including 2,811 SCI papers, and since 2006, a total of 660 papers have an impact factor greater than 3. The published SCI papers and citation rate have remained among the top 15 national scientific research institutions for seven consecutive years, ranking first among national pharmaceutical schools and scientific research institutions.
In 2014, Shanghai Institute of Materia Medica published 540 SCI papers, with a total impact factor (if) of 2310.889, and a total citation frequency of 691 times, (including 272 corresponding authors and a total impact factor of 1167.62 , with a total citation frequency of 294 times), an average impact factor of 4.279, an average citation frequency of 1.28 times per article, an impact factor of 5, 121 papers above, and 317 papers above 3. In GPCR, chemical proteomics Important breakthroughs were made in research and analysis of kinetic simulations, new structures, and new technologies. The crystal structure of the complex of P2Y12 with agonists and antagonists was analyzed for the first time, providing an important foundation for the development of new antithrombotic drugs. Two papers were published in 2014 After the same period was published in Nature on May 1, 2017, it was reported by Xinhua News Agency, Reuters and other domestic and foreign media. Project commitments In 2014, the Shanghai Institute of Materia Medica had 425 ongoing research projects, including 44 major national science and technology projects. It presided over (or undertook) the National Key Basic Research Development Plan (973 Plan) and the National Major Scientific Research Plan. 15 projects, undertook (or participated in) 8 projects, chaired (or undertook) the National High-Tech Research and Development Program (863 Plan), 5 projects, chaired (or undertook) 6 National Natural Science Foundation key projects, and 73 general projects projects, 8 National Science Fund for Distinguished Young Scholars projects, 2 key projects of the National Natural Science Foundation of China Major Research Plan, hosted (or assumed) 1 strategic leading science and technology project of the Chinese Academy of Sciences, hosted (or assumed) 2 key deployment projects of the Academy , undertaking 2 key international cooperation projects. Patents and Others In 2014, Shanghai Institute of Materia Medica applied for 98 patents and obtained 40 patent authorizations, including 33 domestic patents, 7 foreign patents, and 1 trademark registration.
"Acta pharmacologica Sinica" "Acta pharmacologica Sinica" (Acta Pharmacologica Sinica) was founded in 2000 as a monthly publication. It is currently included in PubMed and included in SCI. Its research field is: pharmacology. It is the only academic journal in the field of pharmacology and pharmacy in China that is included in the Science Citation Index (SCI), with an impact factor (IF) of 2.468. "Asian Journal of Andrology" "Asian Journal of Andrology" was founded in 1999. It is an important international journal of intercontinental societies in China. It has an impact factor of 2.530 and ranks No. 1 among international journals in the field of Andrology. Third, it ranks first in the domestic SCI journal list in the field of clinical medicine.
In addition, the institute also sponsors the popular science magazine "Household Medicine".